Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohortJeremie Calais, Andrei Gafita, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective StudyRiccardo Mei, Lukas Kessler, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective StudyWolfgang Peter Fendler, Jeremie Calais, Martin Allen-Auerbach, et al.
Plant Molecular Biology|December 30, 2016
Long-term T-DNA insert stability and transgene expression consistency in field propagated sugarcaneKerry Hosmer Caffall, Chengkun He, Michele Smith-Jones, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 13, 2021
Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trialAmelia K Smit, Martin Allen, Brooke Beswick, et al.
Thorax|May 9, 2022
COVID-19-related changes in outpatient CPAP setup pathways for OSA are linked with decreased 30-day CPAP usageChris D Turnbull, Martin Allen, Jennifer Appleby, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II StudyAmar U Kishan, Luca F Valle, Holly Wilhalme, et al.
Nature Communications|July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progenyTheodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
Pageof 8